Product phospholipids -phospholipid-peg-customization

Home > products > phospholipids > phospholipid-peg-customization

Catalog	name	Description	price
R-C-5016	DSPE-PEG-A7RD（DRDPDPDLDWDTDA）	DA7R (DRDPDPDLDWDTDA) is a ligand for vascular endothelial growth factor receptor-2 (VEGFR2) and neurociliary protein-1 (NRP-1). By comparing GICP, DA7R, and DA7R-GICP, it was found that DA7R-GICP is a targeted peptide that does not affect the binding sites of the two peptides and can improve their enzyme stability.	price>
R-C-5017	DSPE-PEG350-A7RD（DRDPDPDLDWDTDA）	DA7R (DRDPDPDLDWDTDA) is a ligand for vascular endothelial growth factor receptor-2 (VEGFR2) and neurociliary protein-1 (NRP-1). By comparing GICP, DA7R, and DA7R-GICP, it was found that DA7R-GICP is a targeted peptide that does not affect the binding sites of the two peptides and can improve their enzyme stability.	price>
R-C-5018	DSPE-polyethylene glycol550-A7RD	DA7R (DRDPDPDLDWDTDA) is a ligand for vascular endothelial growth factor receptor-2 (VEGFR2) and neurociliary protein-1 (NRP-1). By comparing GICP, DA7R, and DA7R-GICP, it was found that DA7R-GICP is a targeted peptide that does not affect the binding sites of the two peptides and can improve their enzyme stability.	price>
R-C-5019	A7RD-PEG750-DSPE	DA7R (DRDPDPDLDWDTDA) is a ligand for vascular endothelial growth factor receptor-2 (VEGFR2) and neurociliary protein-1 (NRP-1). By comparing GICP, DA7R, and DA7R-GICP, it was found that DA7R-GICP is a targeted peptide that does not affect the binding sites of the two peptides and can improve their enzyme stability.	price>
R-C-5020	DSPE-PEG-tyrosine	1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol mainly applicated in new drug-release,nanotechnology,polypeptide synthesis support,and polyethylene glycol-modified functional coatings and other aspects of the active compound.	price>
R-C-5021	DSPE-PEG350-tyrosine	1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol mainly applicated in new drug-release,nanotechnology,polypeptide synthesis support,and polyethylene glycol-modified functional coatings and other aspects of the active compound.	price>
R-C-5022	DSPE-polyethylene glycol550-tyrosine	1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol mainly applicated in new drug-release,nanotechnology,polypeptide synthesis support,and polyethylene glycol-modified functional coatings and other aspects of the active compound.	price>
R-C-5023	tyrosine-PEG750-DSPE	1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-polyethylene glycol mainly applicated in new drug-release,nanotechnology,polypeptide synthesis support,and polyethylene glycol-modified functional coatings and other aspects of the active compound.	price>
R-C-5024	PLGA-PEG-CLPVASC	The COOH-terminal thiol group on CLPVASC-ELP will allow thiolated drugs or other small-molecule drugs with thiol cleavable linkers to be attached for kidney-specific delivery.	price>
R-C-5027	CLPVASC-PEG750-PLGA	The COOH-terminal thiol group on CLPVASC-ELP will allow thiolated drugs or other small-molecule drugs with thiol cleavable linkers to be attached for kidney-specific delivery.	price>

...